MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.btre.2025.e00940

Медицинская библиотека · Biotechnology reports (Amsterdam, Netherlands) · 2025

Pathogenesis and advances in immunotherapy for type 1 diabetes treatment.

Linh Tran Chi, Dung Nguyen Khanh

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Type 1 diabetes (T1D) is an autoimmune disease marked by selective destruction of pancreatic β-cells, resulting in absolute insulin deficiency. Although insulin replacement remains the standard therapy, it does not address the underlying autoimmune process or prevent long-term complications. Advances in understanding the pathogenesis have highlighted the interaction of genetic susceptibility, environmental triggers, and immune dysregulation, paving the way for innovative immunotherapies. Current strategies include nonspecific immunosuppressants, monoclonal antibodies (e.g., teplizumab, rituximab), peptide vaccines, and cell-based therapies such as regulatory T cells and stem cells. Among these, teplizumab has gained FDA approval to delay disease onset in high-risk individuals, representing a milestone in preventive intervention. Nevertheless, limited durability, high costs, and safety concerns restrict broader clinical application. Looking forward, personalized treatment strategies, rational drug combinations, and early preclinical interventions are expected to optimize outcomes, offering new hope for improving prognosis and quality of life in T1D patients.

Для цитирования: Linh Tran Chi, Dung Nguyen Khanh. Pathogenesis and advances in immunotherapy for type 1 diabetes treatment.. Biotechnology reports (Amsterdam, Netherlands). 2025. DOI: 10.1016/j.btre.2025.e00940.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.